APA (7th ed.) Citation

Nawale, R., Pol, S., Puranik, P., Daud, A., & Rajkondawar, V. (2018). ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DABIGATRAN ETEXILATE RELATED SUBSTANCE IN PHARMACEUTICAL DOSAGE FORM BY REVERSE‑PHASE – HIGH‑PERFORMANCE LIQUID CHROMATOGRAPHY. Asian Journal of Pharmaceutical and Clinical Research; Vol 11 Issue 10 October 2018; 357-364.

Chicago Style (17th ed.) Citation

Nawale, Rajesh, Shankar Pol, Prashant Puranik, Anwar Daud, and Vishal Rajkondawar. "ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DABIGATRAN ETEXILATE RELATED SUBSTANCE IN PHARMACEUTICAL DOSAGE FORM BY REVERSE‑PHASE – HIGH‑PERFORMANCE LIQUID CHROMATOGRAPHY." Asian Journal of Pharmaceutical and Clinical Research; Vol 11 Issue 10 October 2018; 357-364 2018.

MLA (9th ed.) Citation

Nawale, Rajesh, et al. "ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DABIGATRAN ETEXILATE RELATED SUBSTANCE IN PHARMACEUTICAL DOSAGE FORM BY REVERSE‑PHASE – HIGH‑PERFORMANCE LIQUID CHROMATOGRAPHY." Asian Journal of Pharmaceutical and Clinical Research; Vol 11 Issue 10 October 2018; 357-364, 2018.